C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2011
09/27/2011	CA2279476C Novel antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions
09/27/2011	CA2213331C Chemokine receptors 88-2b [ckr-3] and 88c and their antibodies
09/22/2011	WO2011116391A1 Bmp-2 peptides & methods of use
09/22/2011	WO2011116353A2 Method for regulating survival and memory of t helper 1 cells
09/22/2011	WO2011116125A2 Multilayered vascular tubes
09/22/2011	WO2011116117A2 Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions
09/22/2011	WO2011115801A1 Adjuvant phase inversion concentrated nanoemulsion compositions
09/22/2011	WO2011115381A2 Three-dimensional artificial scaffold and method for manufacturing same
09/22/2011	WO2011115308A1 Method for inducing differentiation of pluripotent stem cells into mesodermal cells
09/22/2011	WO2011115288A1 Mutant reductase
09/22/2011	WO2011115231A1 Osteopontin specific monoclonal antibody
09/22/2011	WO2011114920A1 Environmental stress-resistant plant and method for breeding same
09/22/2011	WO2011114719A1 Method of culturing pancreatic islet-like tissues by a tissue complex of pancreas-derived non-endocrinal epithelial cells and vascular endothelial cells
09/22/2011	WO2011114313A1 Plants having enhanced yield-related traits and method for making the same
09/22/2011	WO2011114305A1 Plants having enhanced yield-related traits and method for making the same
09/22/2011	WO2011114237A2 Composition and method for enabling proliferation of pluripotent human stem cells
09/22/2011	WO2011113924A1 A system and method for automated extraction of multi-cellular physiological parameters
09/22/2011	WO2011113220A1 Bioreactor, control system and method thereof
09/22/2011	WO2011088288A8 Hybridoma cell lines and monoclonal antibodies recognizing anthrose saccharide of bacillus anthracis
09/22/2011	WO2011060374A3 Method, kit or diagnostic for the detection of reagents which induce altered contractility
09/22/2011	WO2011058300A3 Induced pluripotent stem cell
09/22/2011	WO2011056971A3 Episomal reprogramming with chemicals
09/22/2011	US20110231964 Sclerotinia-resistant Brassica
09/22/2011	US20110231963 Modified bacillus thuringiensis cry14 proteins for nematode control
09/22/2011	US20110231962 Transgenic bioluminescent plants
09/22/2011	US20110231961 Metabolic regulators
09/22/2011	US20110231960 Bacterial toxin vaccine
09/22/2011	US20110231958 Transgenic plants and fungi capable of metabolizing phosphite as a source of phosphorus
09/22/2011	US20110231955 EFFICIENT GENE SILENCING IN PLANTS USING SHORT dsRNA SEQUENCES
09/22/2011	US20110231954 Gl9 transcriptional control sequences
09/22/2011	US20110231953 Transformed plant with increased chloroplasts per cell
09/22/2011	US20110231952 Soybean nodulation factor receptor proteins, encoding nucleic acids and uses therefor
09/22/2011	US20110231951 Clubroot resistance brassica oleracea plants
09/22/2011	US20110231946 Engineering of bolting resistance in sugar beet by means of the transgenic expression of the beet homologue of flowering time control gene ft
09/22/2011	US20110231944 B cell-derived ips cells and application thereof
09/22/2011	US20110231942 Tiki1 and tiki2, wnt inhibitors
09/22/2011	US20110230642 Method for increasing recloning efficiency
09/22/2011	US20110230637 Modified human thymic stromal lymphopoietin
09/22/2011	US20110230556 Diglycidic Ether Derivative Therapeutics and Methods for Their Use
09/22/2011	US20110230551 Withaferin a analogs and uses thereof
09/22/2011	US20110230548 Multicistronic vectors and methods for their design
09/22/2011	US20110230546 dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION
09/22/2011	US20110230545 Eml4-alk fusion gene
09/22/2011	US20110230544 Modulation of c-reactive protein expression
09/22/2011	US20110230542 Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
09/22/2011	US20110230540 Manassatin compounds and methods of making and using the same
09/22/2011	US20110230539 Small Molecule Inhibitors of N-Terminus Activation of the Androgen Receptor
09/22/2011	US20110230503 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions
09/22/2011	US20110230487 Arylsulfonamide ccr3 antagonists
09/22/2011	US20110230451 Identification and use of compounds that affect the fidelity of eukaryotic translation initiation codon selection
09/22/2011	US20110230442 Na channels, disease, and related assays and compositions
09/22/2011	US20110230430 Saponin extract from saponaria spp. and uses thereof
09/22/2011	US20110230425 Compositions for protection and cellular delivery of interfering rna
09/22/2011	US20110230422 Purging of an ex vivo hematopoietic stem cell culture of cancer cells
09/22/2011	US20110230420 Releasable conjugates for nucleic acids delivery systems
09/22/2011	US20110230411 Albumin fibers and fabrics and methods of generating and using same
09/22/2011	US20110230401 Insulin fusion polypeptides
09/22/2011	US20110230393 Antibacterial Phage Peptides and Methods of Use thereof
09/22/2011	US20110230392 Novel narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, and narc 25 molecules and uses therefor
09/22/2011	US20110230369 Method for screening compounds for their ability to increase rigidity of red blood cells infected by a protozoan parasite of the genus plasmodium, method for filtering red blood cells, and application thereof
09/22/2011	US20110229970 Dual-chamber perfusion bioreactor for orthopedic tissue interfaces and methods of use
09/22/2011	US20110229969 Cell Line for Propagation of Highly Attenuated AlphaViruses
09/22/2011	US20110229967 Method of culturing conifer somatic embryos using s(+)-abscisic acid
09/22/2011	US20110229966 Nanoparticle-Based Gene Delivery Systems
09/22/2011	US20110229965 Methods of Preparing Mesenchymal Stem Cells, Compositions and Kit Thereof
09/22/2011	US20110229964 Fusion Protein Delivery System and Uses Thereof
09/22/2011	US20110229956 Novel Variant Hyprocrea Jecorina CBH1 Cellulases
09/22/2011	US20110229955 Luciferases and methods for making and using the same
09/22/2011	US20110229944 FAD4, FAD5, FAD5-2, AND FAD6, Novel Fatty Acid Desaturase Family Members and Uses Thereof
09/22/2011	US20110229933 High titer antibody production
09/22/2011	US20110229932 Artificial chromosome vector
09/22/2011	US20110229931 Engineering intracellular sialylation pathways
09/22/2011	US20110229908 Methods and products for measuring free immunoglobulin light chain molecules
09/22/2011	US20110229880 Gene silencing
09/22/2011	US20110229875 Method of measuring human cyp3a inducibility
09/22/2011	US20110229874 Compositions and methods useful for hcv infection
09/22/2011	US20110229871 Nucleoside-containing compositions and methods for treating red blood cells
09/22/2011	US20110229870 Disintegration of cellular components in body fluids
09/22/2011	US20110229581 Releasable cationic lipids for nucleic acids delivery systems
09/22/2011	US20110229579 Support Having Nanostructured Titanium Dioxide Film And Uses Thereof
09/22/2011	US20110229576 Hollow silica nanospheres and methods of making same
09/22/2011	US20110229552 NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN
09/22/2011	US20110229529 Lipid vesicle compositions and methods of use
09/22/2011	US20110229525 Modulation of cytokine signaling
09/22/2011	US20110229509 Polypeptides for inducing a protective immune response against staphylococcus aureus
09/22/2011	US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9
09/22/2011	US20110229504 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
09/22/2011	US20110229498 Compositions and methods for modulating an immune response
09/22/2011	US20110229496 Method for regulating survival and memory of t helper 1 cells
09/22/2011	US20110229489 Antibodies with pH Dependent Antigen Binding
09/22/2011	US20110229484 Host Cell Kinases as Targets for Antiviral Therapies Against HCV Infection
09/22/2011	US20110229482 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood by preventing viral entry into a cell
09/22/2011	US20110229481 Cancer-associated antigen analogue peptides and uses thereof
09/22/2011	US20110229480 Pta072 protein
09/22/2011	US20110229478 Erbb3 based methods and compositions for treating neoplasms
09/22/2011	US20110229477 Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
09/22/2011	US20110229475 Novel compounds
09/22/2011	US20110229472 Peptides and Related Compounds Having Thrombopoietic Activity
09/22/2011	US20110229466 Vascular endothelial growth factor 2
09/22/2011	US20110229463 Recombinant anti-epidermal growth factor receptor antibody compositions

1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 1827